- Felip, E., Shaw, A. T., Bearz, A., Camidge, D. R., Solomon, B. J., Bauman, J. R., . . . Besse, B. (2021). Intracranial and extracranial efficacy of lorlatinib in patients with ALK-positive non-small-cell lung cancer previously treated with second-generation ALK TKIs. Annals of Oncology. https://doi.org/10.1016/j.annonc.2021.02.012 (Article en premsa)
Intracranial and extracranial efficacy of lorlatinib in patients with ALK-positive non-small-cell lung cancer previously treated with second-generation ALK TKIs
on 29 de març de 2021
with No hi ha comentaris
Deixa un comentari